p=0.209790), nor Access Duration x Treatment (F(1,28)=0.4833
Its always a good idea to talk to your healthcare professional about any concerns you may have
Your GI tolerance resets
At the American College of Cardiology's (ACC) Annual Scientific Session and Expo, Novo Nordisk presented important findings from its Phase 3b STRIDE trial, which investigated the impact of a once-weekly 1 mg dose of Ozempic (semaglutide) on adults with type 2 diabetes and early-stage symptomatic peripheral artery disease (PAD)
This article reports what has been documented, not what should be done
Additional analyses of the early MACE separation for semaglutide versus placebo by individual MACE components, additional clinical outcomes, patient subgroups, and other parameters changing during the early post-randomisation stages of the trial will be provided, the authors note